Aurora Cannabis Inc T.ACB

Alternate Symbol(s): T.ACB.WS.U | ACB

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by BrunosBreweryon May 26, 2017 9:38am

203 Views

Post# 26287433

RE:RE:Conclusion - ACB is being bought out

A recall doesn't take a halt. OGI never even needed to halt with their massive recall. Only negotiating a deal would take this long

Birdsplitter wrote:

BrunosBrewery wrote: A buyout of ACB is honestly the only conclusion I'm left to come too. Otherwise this halt would be long over with. If this is the case though, this is a massive company that will be purchasing ACB EG. Big Pharma. In this case, Big Pharma will also be purchasing the MOU with RTI. This will make the current MOU between ACB and RTI, ALOT more valuable. For instance, if Big Pharma signed an MOU with RTI, what do you think our current share price would be? And what will it be after an exclusive partnership is reached? Would not a giant pharmacy company also have a lot more use for RTI's extraction technologies to aid in the development of a whole host of other pharmaceuticals?

No way... the news would have been out by now..... Most likely a recall.. all other reasons would be out almost immediately